Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
about
Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat modelThymoquinone attenuates cisplatin-induced hepatotoxicity via nuclear factor kappa-βFerulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic KidneyOat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic RatsOat Protects against Diabetic Nephropathy in Rats via Attenuating Advanced Glycation End Products and Nuclear Factor Kappa B.Regulatory landscape of AGE-RAGE-oxidative stress axis and its modulation by PPARγ activation in high fructose diet-induced metabolic syndrome.Fenugreek attenuation of diabetic nephropathy in alloxan-diabetic rats: attenuation of diabetic nephropathy in rats.Proanthocyanidin Attenuation of Oxidative Stress and NF- κ B Protects Apolipoprotein E-Deficient Mice against Diabetic Nephropathy.Bees' honey attenuation of metanil-yellow-induced hepatotoxicity in rats.Potential protective effects of oral administration of allicin on acrylamide-induced toxicity in male mice.Trigonella foenum-graecum ameliorates acrylamide-induced toxicity in rats: Roles of oxidative stress, proinflammatory cytokines, and DNA damage.Protective Effects of Thymoquinone Against Convulsant Activity Induced by Lithium-Pilocarpine in a model of Status Epilepticus.Ferulsinaic acid attenuation of diabetic nephropathy.Rosiglitazone attenuates indoxyl sulphate-induced endothelial dysfunction.MicroRNA-146a: A Comprehensive Indicator of Inflammation and Oxidative Stress Status Induced in the Brain of Chronic T2DM Rats.
P2860
Q34653233-55C2D047-BCA9-4E2E-AF13-5300CAAC50C8Q35218040-EF1A9B04-F11F-4913-8AA9-2EA4DCE45AB8Q36237698-F10F2CC7-E19A-4E2C-A629-A4874EEB0CF1Q36566092-FE59C974-0C0B-4EB2-B5AC-72C1AA439616Q37261237-20835375-3D7C-4749-8157-B8B014C16E7AQ37586657-35A39110-16BB-4ABB-B2F4-B43C2E2CCC5BQ39665324-F71A3D96-CE90-4302-8D11-416BC5A13D39Q42013303-521FE612-1CD8-460A-A2FE-A99254912329Q42158151-26F832BD-AC88-4D73-8448-872D7E3E571CQ44657008-AC1B732C-6B3A-4168-93FB-5A65AFDF95CAQ46894625-6F7E60EF-58A5-4E00-8C2C-6064C86B6335Q48295769-E5F87906-817A-463C-BFBD-A954C46AAE7FQ51348340-5CA8D7D5-FB8A-4A94-866A-909761C83844Q53674702-D9CFCD27-88CE-4D44-9C22-909C1530AB63Q55279635-CE91BB7B-2DC6-44F9-AB7A-B1DECEE2B831
P2860
Rosiglitazone reduces angiotensin II and advanced glycation end product-dependent sustained nuclear factor-kappaB activation in cultured human proximal tubular epithelial cells.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@en
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@nl
type
label
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@en
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@nl
prefLabel
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@en
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@nl
P2093
P356
P1476
Rosiglitazone reduces angioten ...... imal tubular epithelial cells.
@en
P2093
A A R Sayed
A Bierhaus
A Schlotterer
D Oikomonou
F Bozorgmehr
F Pfisterer
F van der Woude
P304
P356
10.1055/S-0028-1082039
P577
2008-08-18T00:00:00Z